First quarter total revenue of approximately EUR 5.9 million ( USD 7.8 million ), up 23% year-over-year Ten lithotripsy devices sold in first quarter 2013 Received FDA acceptance for PMA filing on March 26, 2013 , for Ablatherm®-HIFU for treatment of low risk, localized prostate cancer LYON, France
EDAP Announces Ablatherm Fusion World Premiere during American Urology Association Annual Meeting in Boston, MA , May 12-16, 2017 EDAP to Showcase Ablatherm Fusion and Sonolith i-move at AUA Booth #130 LYON, France , May 11, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic
Multicenter study to commence in September in France Reinforces company’s recent shift in strategic focus toward development of additional high-value HIFU tissue ablation indications LYON, France , August 25, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic
Study to begin enrolling patients in Q2 2023 Endometriosis represents significant expansion opportunity for Focal One LYON, France, November 30, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic therapeutic ultrasound, today announced that the Company has
Billing code will take effect July 1st, 2017 LYON, France , May 22, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the Centers for Medicare and Medicaid Services (CMS) have established a new billing code for HIFU ablation of
60 Patients Completed Enrollment in Under 9 Months Study Results Expected in the Second Half of 2024 LYON, France, February 1, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced today that it has completed enrollment in its Phase 3 study (Endo-HIFU-R2)
EDAP Announces Details on Termination Agreement With HealthTronics LYON, France, April 12 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (NASDAQ: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production,